Advancing global healthcare resilience

Advancing global healthcare resilience: amplifying impact through BMJ Collections Academic Clinical Lecturer in Infectious Diseases and Global Health, Dr Derek Cocker, is an infectious disease researcher focusing on innovative strategies to combat antimicrobial resistance (AMR) and strengthen healthcare resilience. His expertise spans system wide ...

2026-04-09T13:24:06+01:0010 December 2024|Collection, Corporate announcement, Our impact|

Advocating for safer pharmaceutical marketing

How patient voices can drive meaningful change Nearly 90% of teens and young adults who use social media say they use it to find information about their healthcare. However, as pharmaceutical marketers have shifted more and more of their budgets towards selling their products on social media, especially via ...

2026-04-09T13:24:07+01:0020 November 2024|Corporate announcement, Our impact|

Advancing health priorities in China through BMJ Collections

In 2024, The BMJ launched two impactful Collections to help advance health priorities in China. These Collections focused on two pressing health issues: women's health and chronic disease management. Both were launched at high profile academic and policy events, receiving significant attention from healthcare professionals, researchers, and the public. This ...

2026-04-09T13:24:08+01:0019 November 2024|Corporate announcement, Launch, Our impact, Partnership|

Celebrating a decade of patient and public partnership

Improving healthcare and health systems We partner with patients and the public across all aspects of our work. Their insights bring a critical dimension to our work and thinking: partnerships with patients, carers, community support networks, and the public will create better evidence." Dr Kamran Abbasi Editor ...

2025-06-25T14:39:56+01:0013 September 2024|Our impact|

BMJ TAG: making meaningful contributions to patient care

In the last year, the BMJ Technology Assessment Group (BMJ-TAG) has played a key role in evaluating the safety and effectiveness of drugs for public use through the NHS, contributing to the development of high profile NICE guidance. In July 2023, rimegepant was recommended for use in the NHS ...

2025-06-26T07:54:20+01:005 September 2024|Our impact|

BMJ Group expands its open access offering globally with new partnerships

Multiple open access partnerships in Italy, Turkey, and the Netherlands solidify BMJ’s commitment to global knowledge dissemination June 2024—Leading global healthcare knowledge provider, BMJ, continues to expand its open access (OA) footprint worldwide through new Read and Publish (R&P) agreements. These partnerships signify ongoing efforts to enhance access to cutting-edge ...

Go to Top